Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.
about
Multifactorial analysis of predictors of outcome in pediatric intracranial ependymomaSurvivin 2alpha: a novel Survivin splice variant expressed in human malignanciesAberrant regulation of survivin by the RB/E2F family of proteinsSurvivin splice variants regulate the balance between proliferation and cell deathNuclear or cytoplasmic expression of survivin: what is the significance?A prognostic gene expression signature in infratentorial ependymoma.Role of the Survivin gene in pathophysiologyMolecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapyExpression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma.Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivoSurvivin: a target from brain cancer to neurodegenerative disease.Ependymoma in children: molecular considerations and therapeutic insights.Differential gene expression and alternative splicing of survivin following mouse sciatic nerve injury.Molecular docking and analysis of survivin delta-ex3 isoform protein.Molecular interaction of Survivin and Piperine by computational docking analyses for neuroblastoma targeting.EGFR as a predictor of relapse in myxopapillary ependymoma.Aurora B kinase expression in laryngeal squamous cell carcinoma and its prognostic implications.
P2860
Q24646111-4F126562-9112-4F77-BD71-118139660BA1Q24802579-E5230A41-3B7F-4BA9-A05D-35729C218380Q28273531-DBE85891-FDD3-4F61-A6C3-8CD86FED30BCQ28305497-760852EE-921F-40EC-81B0-57D6EE82EE43Q28748709-A1A6C88B-D74C-4322-A6AF-739A171EE901Q33581494-116BEEC8-5826-421B-8039-E6EEAA406968Q35221844-5E5FCFC2-D87B-4DEB-BFFF-D413D84E00CEQ36118431-23FE6D8F-16BE-42A0-9CE8-4F06B5984178Q36536409-3214888B-BB6C-498F-8E41-C4B03909EDBAQ36613456-1B8E63D1-53C7-4F33-9FBC-76EDA7486D21Q36616158-3E7EFA78-74D1-4820-8DE1-E24F21A17387Q36930279-A677D3C4-582D-4A85-AAAE-B0F1635341B5Q37798272-040E57F0-DF19-44C6-AF24-F66D6BE93169Q38101501-F187F9C0-4B0B-4789-8DAF-E52A12689EA5Q39991014-DAA94F3F-76A9-4698-84B4-0DC4BC2E0C48Q41845070-B0C78903-1D3C-489C-AA2F-E0BE62CFCE6BQ41859701-73D147DB-9031-4F1E-8845-40B1BF4BD7DCQ54541437-09438A84-B578-4498-B6BC-902B62A622B5Q54614871-D103CB0F-F529-493B-BE5C-37CDE18828E1
P2860
Nuclear expression of Survivin in paediatric ependymomas and choroid plexus tumours correlates with morphologic tumour grade.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Nuclear expression of Survivin ...... with morphologic tumour grade.
@en
type
label
Nuclear expression of Survivin ...... with morphologic tumour grade.
@en
prefLabel
Nuclear expression of Survivin ...... with morphologic tumour grade.
@en
P2093
P2860
P356
P1476
Nuclear expression of Survivin ...... with morphologic tumour grade.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601334
P407
P577
2003-11-01T00:00:00Z
P5875
P6179
1041798952